Shares in EBR Systems Ltd (ASX: EBR) have been on the slide over the past six months, and they’re now languishing not too far off their 12-month lows.

Naturally this begs the question, are they cheap at the moment?

The analyst team at Bell Potter thinks so and has a speculative buy recommendation on the company, along with a bullish share price target, which I’ll get to shortly.

First let’s look at what the company has been up to.

Solid progress on technology sales

EBR has developed a system called WiSE which it says is designed to overcome the limitations of conventional cardiac resynchronisation therapy and, “is the only leadless left ventricular endocardial pacing (LVEP) device”.

The company recently released a quarterly report and said that it had surpassed its hundredth commercial WiSE implant, “with multiple sites performing their first WiSE implants and numerous sites performing their 2nd, 3rd, 4th, and greater cases”.

The company also completed the first two tranches of a fully underwritten $150 million capital raise with the final $35 million expected to be completed by August 24.

EBR Chief Executive Officer John McCutcheon said:

We are extremely pleased with this quarter on multiple fronts. Commercially, EBR surpassed its 100th commercial WiSE implant, with multiple sites performing their first WiSE implants and numerous more experienced sites continuing to treat patients with WiSE. We secured master purchasing agreements with HCA Healthcare, Advocate Health, and CHRISTUS Health, validating the clinical and economic benefit of WiSE in major U.S. healthcare networks. In support of our future commercial efforts, the U.S. Centers for Medicare & Medicaid Services (CMS) further advanced WiSE through the Transitional Coverage for Emerging Technology (TCET) program by formally initiating the National Coverage Determination process for WiSE.

The company also fully transitioned to its new manufacturing facility in California, Mr McCutcheon said.

During the quarter EBR had operating cash outflows of $25 million.

Shares are looking cheap but more capital needed

In a note to clients released after the quarterly results, Bell Potter said that EBR’s cash receipts were still modest at US$3.6 million for the quarter but had doubled in the period. Bell Potter also noted that the company has five quarters’ worth of cash on hand.

The broker believes the company will need to raise more capital, and has therefore reduced its share price target on EBR to 70 cents, down 22%. This is still well above the current share price of 28 cents.

The broker added:

This still represents significant upside potential, but the need for more funding may weigh on investor sentiment. We retain our BUY (Spec.) rating.

EBR is valued at $214.7 million.

The post Bell Potter tips more than 140% upside for this out of favour ASX biotech appeared first on The Motley Fool Australia.

More reading

• Why I’d buy Telstra, Woolworths, and Macquarie shares
• Australian Strategic Materials: Federal Court approves Energy Fuels takeover
• Healthcare results wrap: Are Cogstate and Pro Medicus shares a buy, hold or sell?
• Why did this ASX gold stock just soar 24% in a single session?
• BCI Minerals: SOP pilot plant contract awarded

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

In 2025, ASX gold stocks surged as record gold prices, geopolitical uncertainty and expectations of lower interest rates boosted safe-haven demand and expanded miners’ profit margins, with several major stocks doubling or more.

As the calendar ticked over to 2026, many of the biggest winners initially fell as valuations became stretched and gold experienced a sharp correction. 

However research from VanEck suggests ASX gold stocks are more resilient than investors might have thought. 

One ASX gold stock worth monitoring is Ausgold Ltd (ASX: AUC). 

It soared 24% yesterday after a key announcement to the ASX. 

What did the company announce?

As reported yesterday by Laura Stewart, Ausgold Ltd (ASX: AUC) announced a recommended scheme of arrangement under which OceanaGold Corp (TSE: OGC) will acquire 100% of Ausgold, valuing each Ausgold share at an implied A$1.36 and the total company at approximately A$776 million. 

The scheme is subject to regulatory and court approvals, as well as an independent expert’s conclusion that the deal is in shareholders’ best interests.

For investors, this $1.36 price represented a 28% premium at the time. 

However, after the massive climb during Tuesday’s session, the stock price is now hovering just below at $1.32. 

Following the announcement, the team at Bell Potter issued updated guidance on the ASX gold stock. 

Here is what the broker had to say. 

Downgraded outlook 

Bell Potter downgraded its outlook on this ASX gold stock to a speculative hold following OceanaGold’s proposed ~$776m acquisition of AUC. 

The all-scrip deal (with up to A$194m cash consideration) is unanimously recommended by the AUC Board, with major shareholder Dundee Resources also intending to support it. 

Completion is targeted for December 2026, after which AUC shareholders would own ~6–8% of OceanaGold, gaining exposure to its four producing gold assets while retaining Katanning development upside with substantially lower funding and execution risk. 

Bell Potter views OceanaGold’s strong balance sheet as sufficient to fund Katanning’s ~$354m development cost and sees relatively low-medium risk of a competing bidder. 

The proposed transaction implies A$282/oz of resources, well above the A$202/oz average for selected Australian gold deals in 2024–25, supporting the view that the offer is attractive. 

Some upside remains

Based on this guidance, Bell Potter lowered its price target to $1.50 (previously $1.70) on this ASX gold stock. 

From yesterday’s closing price, this indicates upside potential of 13%. 

We downgrade to a Hold recommendation and lower our valuation to $1.50/sh, a 10% premium to the initial offer price recognising that AUC is in-play and its share price should reflect OGC’s share price and gold price movements. We see low-medium interloper risk.

The post Why did this ASX gold stock just soar 24% in a single session? appeared first on The Motley Fool Australia.

More reading

• Healthcare results wrap: Are Cogstate and Pro Medicus shares a buy, hold or sell?
• Ausgold shares in focus after OceanaGold’s $776m takeover offer
• Are A2 Milk shares a buy, hold or sell following results?
• 3 ASX shares tipped to explode up to 72% in the back half of 2026
• This ASX industrials stock just rocketed 13% on results and is expected to keep rising

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Yesterday, BCI Minerals Ltd (ASX: BCI) announced it had been awarded a construction contract for a new sulphate of potash (SOP) pilot plant at its flagship Mardie Salt Operation and Potash Project. This pilot plant marks a major step towards validating commercial-scale SOP production from the Mardie feedstock.

What did BCI Minerals report?

• Construction contract awarded for a 150 kg/hr SOP pilot plant at Mardie Salt Operation
• Pilot plant expenditure funded within the approved A$1.443 billion Mardie project budget
• Commissioning targeted for the start of Q2 FY2028, with 12-month piloting phase
• Approximately 1,000 tonnes of representative KTMS feedstock to be produced in Q2 FY2027
• Bluestar Lehigh Engineering Institute Co, Ltd engaged as lead designer and constructor

What else do investors need to know?

The new SOP pilot plant will allow BCI Minerals to test the value-adding potential of converting bitterns into high-value, premium fertiliser products onsite. This staged investment is intended to support continuous, end-to-end testing under operating conditions to refine technical and process design before any large-scale decisions are made.

The pilot initiative is fully funded from BCI’s existing project resources, meaning no change to the scope or schedule of the Mardie salt operation. The independent consultancy eXcellerate will provide oversight across design, risk, procurement, and commissioning, with a view to ensuring robust, reliable results.

What did BCI Minerals management say?

Managing Director David Boshoff said:

The SOP pilot plant is an important next step in BCI’s disciplined approach to maximising the value of the Mardie resource. It will allow us to assess the value-adding of bitterns into SOP, with the potential for Mardie to become Australia’s only operation producing both salt and SOP on one site. Piloting is the disciplined way to approach SOP. It gives us realistic, continuous end-to-end data on feed material in our own operating environment, which is exactly what we need to finalise a robust flowsheet and reduce technical and process uncertainty before any future full-scale investment decision. We are funding this entirely from within the existing approved project budget, and it does not change the scope or schedule of the Mardie salt operation.

What’s next for BCI Minerals?

BCI Minerals will now focus on producing and processing around 1,000 tonnes of feedstock for the pilot, aiming to commission the new SOP facility at the start of Q2 FY2028. Piloting will run for approximately 12 months, giving the company valuable operational data for refining its SOP process.

Any decision to proceed with a full-scale SOP facility will depend on successful piloting results, further feasibility work, and a separate investment decision. This staged approach supports BCI’s strategy to diversify Mardie’s earnings base and potentially establish a unique Australian operation.

BCI Minerals share price snapshot

Over the past 12 months, BCI Minerals shares have risen 31%, outperforming the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.

View Original Announcement

The post BCI Minerals: SOP pilot plant contract awarded appeared first on The Motley Fool Australia.

More reading

• Why this $1.4 billion ASX All Ords mining stock is tipped to jump 30%
• Brokers name 3 ASX shares to buy with gains of up to 75%

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.